| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
American Journal of Transplantation: Volume 21, Number 8, August 2021
|
|
|
|
21 |
8 |
p. i
|
artikel
|
| 2 |
A rare hepatic malignancy in childhood treated with living donor liver transplantation
|
Carpenter, Jennifer L.
|
|
|
21 |
8 |
p. 2905-2907
|
artikel
|
| 3 |
A short course of tofacitinib sustains the immunoregulatory effect of CTLA4-Ig in the presence of inflammatory cytokines and promotes long-term survival of murine cardiac allografts
|
Iglesias, Marcos
|
|
|
21 |
8 |
p. 2675-2687
|
artikel
|
| 4 |
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
|
Cucchiari, David
|
|
|
21 |
8 |
p. 2727-2739
|
artikel
|
| 5 |
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
|
Caballero-Marcos, Aránzazu
|
|
|
21 |
8 |
p. 2876-2884
|
artikel
|
| 6 |
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis
|
Ehx, Grégory
|
|
|
21 |
8 |
p. 2662-2674
|
artikel
|
| 7 |
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study
|
Heldman, Madeleine R.
|
|
|
21 |
8 |
p. 2774-2784
|
artikel
|
| 8 |
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative
|
Varnell Jr, Charles
|
|
|
21 |
8 |
p. 2740-2748
|
artikel
|
| 9 |
COVID-19 in solid organ transplant recipients: A national cohort study from Sweden
|
Søfteland, John M.
|
|
|
21 |
8 |
p. 2762-2773
|
artikel
|
| 10 |
Distinct immunopathological mechanisms of EBV-positive and EBV-negative posttransplant lymphoproliferative disorders
|
Nakid-Cordero, Cecilia
|
|
|
21 |
8 |
p. 2846-2863
|
artikel
|
| 11 |
Diversity of antibody responses after influenza infection or vaccination—Needed or nice to have?
|
Gärtner, Barbara C.
|
|
|
21 |
8 |
p. 2631-2632
|
artikel
|
| 12 |
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing
|
Kaul, Daniel R.
|
|
|
21 |
8 |
p. 2885-2889
|
artikel
|
| 13 |
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients
|
Malinis, Maricar
|
|
|
21 |
8 |
p. 2916-2918
|
artikel
|
| 14 |
Excess death estimates in patients with end-stage renal disease — United States, February–August 2020
|
Ziemba, Robert
|
|
|
21 |
8 |
p. 2900-2904
|
artikel
|
| 15 |
Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver
|
Bohorquez, Humberto
|
|
|
21 |
8 |
p. 2895-2899
|
artikel
|
| 16 |
Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation
|
Hostetler, Haley P.
|
|
|
21 |
8 |
p. 2864-2870
|
artikel
|
| 17 |
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients
|
Marinaki, Smaragdi
|
|
|
21 |
8 |
p. 2913-2915
|
artikel
|
| 18 |
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
|
Miele, Monica
|
|
|
21 |
8 |
p. 2919-2921
|
artikel
|
| 19 |
Islet cell transplantation hits a milestone
|
Pullen, Lara C.
|
|
|
21 |
8 |
p. 2625-2626
|
artikel
|
| 20 |
Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient
|
Yohanathan, Lavanya
|
|
|
21 |
8 |
p. 2890-2894
|
artikel
|
| 21 |
Long-term kidney transplant graft survival—Making progress when most needed
|
Poggio, Emilio D.
|
|
|
21 |
8 |
p. 2824-2832
|
artikel
|
| 22 |
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19
|
Benotmane, Ilies
|
|
|
21 |
8 |
p. 2871-2875
|
artikel
|
| 23 |
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients
|
Hirzel, Cedric
|
|
|
21 |
8 |
p. 2709-2718
|
artikel
|
| 24 |
Optimizing virus protection in lung transplant recipients: Don’t drop the ball
|
Meyer, Keith C.
|
|
|
21 |
8 |
p. 2633-2634
|
artikel
|
| 25 |
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial
|
Bestard, Oriol
|
|
|
21 |
8 |
p. 2833-2845
|
artikel
|
| 26 |
Preservation of pancreas in the University of Wisconsin solution supplemented with AP39 reduces reactive oxygen species production and improves islet graft function
|
Nishime, Kai
|
|
|
21 |
8 |
p. 2698-2708
|
artikel
|
| 27 |
Public discourse and policy change: Absence of harm from increased oversight and transparency in OPO performance
|
Doby, Brianna L.
|
|
|
21 |
8 |
p. 2646-2652
|
artikel
|
| 28 |
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
|
Grupper, Ayelet
|
|
|
21 |
8 |
p. 2719-2726
|
artikel
|
| 29 |
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
|
Mossad, Sherif Beniameen
|
|
|
21 |
8 |
p. 2908
|
artikel
|
| 30 |
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely
|
Grupper, Ayelet
|
|
|
21 |
8 |
p. 2909
|
artikel
|
| 31 |
Risk and reward: Balancing safety and maximizing lung donors during the COVID-19 pandemic
|
La Hoz, Ricardo M.
|
|
|
21 |
8 |
p. 2635-2636
|
artikel
|
| 32 |
SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients
|
Favà, Alexandre
|
|
|
21 |
8 |
p. 2749-2761
|
artikel
|
| 33 |
Senescence and aging of solid organs? Blame the immune system!
|
Li, Xian C.
|
|
|
21 |
8 |
p. 2627
|
artikel
|
| 34 |
Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients
|
Tau, Noam
|
|
|
21 |
8 |
p. 2910-2912
|
artikel
|
| 35 |
Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes
|
Pham, Phuoc H.
|
|
|
21 |
8 |
p. 2810-2823
|
artikel
|
| 36 |
T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
|
Fernández-Ruiz, Mario
|
|
|
21 |
8 |
p. 2785-2794
|
artikel
|
| 37 |
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined
|
Blumberg, Emily A.
|
|
|
21 |
8 |
p. 2629-2630
|
artikel
|
| 38 |
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy
|
Kates, Olivia S.
|
|
|
21 |
8 |
p. 2637-2645
|
artikel
|
| 39 |
Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial
|
Casiraghi, Federica
|
|
|
21 |
8 |
p. 2795-2809
|
artikel
|
| 40 |
“Time is tissue”—A minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation
|
Heylen, Line
|
|
|
21 |
8 |
p. 2653-2661
|
artikel
|
| 41 |
Uninephrectomy and class II PI3K-C2β inactivation synergistically protect against obesity, insulin resistance and liver steatosis in mice
|
Alliouachene, Samira
|
|
|
21 |
8 |
p. 2688-2697
|
artikel
|
Tijdschrift beschrijving